IP Law 360 and International Trade Law 360 Article has published an article, Five Ways U.S. Innovation Can Benefit from China’s $586 Billion Stimulus Plan, by Lei Mei of Mei & Mark LLP. The article will appear in the IP Law 360 and International Trade Law 360 newsletter publications on Monday, November 23, 2009.
Click here to download a copy.
The original, unedited version of the article is reproduced below:
Five Ways U.S. Innovation Can Benefit from China’s $586 Billion Stimulus Plan
Lei Mei, Partner, Mei & Mark LLP
China’s aggressive $586 billion stimulus plan has increased its domestic consumption and jump-started China’s economic recovery. In the third quarter, China’s economy, driven by spending and a rise in bank lending, expanded to 8.9%, improving from 7.9% in the second quarter. Rarely known, however, is the fact that U.S. innovations can also benefit from China’s stimulus plan. This article unveils five ways to do so.
As a preliminary matter, one must understand first why China is interested in U.S. innovations and what U.S. innovations are in demand.
China is interested in U.S. innovations because the United States is the leader in technology innovations. The United States is one of the strongest brands and a symbol of technological excellence, at least for Chinese businesses and consumers. Consequently, even in China’s automobile market, Chinese consumers generally favor U.S. cars over Japanese cars, in contrast to their U.S. peers.
It did not come as a surprise, therefore, when in recent years Chinese companies launched a shopping spree to purchase ailing U.S. companies, despite strong opposition from U.S. politicians. For example, in 2008, Chinese consumer electronics giant Huawei Technologies offered to purchase 3Com, but that sale was derailed by U.S. national security concerns. Also, this year, a little known Chinese machinery company, Sichuan Tengzhong Heavy Industrial Machinery Co., offered to acquire General Motors’ iconic Hummer brand, and the deal is currently pending.
Naturally, Chinese companies are most interested in technologies related to consumer electronics and other consumer products. Not only do Chinese companies seek to acquire technologies in tangible form, but they also actively seek to acquire intangible IP rights.
In fact, an increasing number of Chinese companies, assisted by China’s stimulus plan, are seeking to purchase patents, especially in consumer electronics. Presently, they are trying to boost their own patent arsenals for defensive purposes, after years of ignorance of IP management, in case their competitors accuse them of patent infringement in the U.S.
For many U.S. companies – whether cash-strapped or profit-minded – cash-rich Chinese companies’ urgent quest for IP rights provides rare opportunities to extract value from U.S. innovations.
Interestingly, both U.S. and Chinese IP rights are of great value to Chinese companies for defensive purposes. Even if a Chinese company gets hammered with a patent infringement lawsuit by a non-Chinese competitor in the U.S., and does not have any strong U.S. patent to counter the lawsuit, having a Chinese patent in the same technology allows the Chinese company to sue the competitor for patent infringement in China. Because China is such a lucrative consumer market, often the competitor cannot afford losing or having setbacks in China, thus becoming more agreeable to resolving the global patent disputes amicably.
Depending on their respective business goals, then, U.S. companies and their Chinese peers may structure IP deals in various ways to benefit both parties. This article covers five common ways U.S. innovations can benefit from China’s stimulus plan.
First, U.S. companies may choose to sell U.S. IP rights that are not part of their core businesses to Chinese companies. Amidst this global recession, many companies are shifting their business strategies, focusing on core businesses. It does not mean, however, that their investment on innovations in other areas cannot be recouped or rewarded. Chinese companies often asked us to help them locate and acquire well-drafted patents in areas from digital processing to telecommunications. These Chinese companies all have excellent cash positions, making them attractive buyers.
Second, U.S. companies may consider creating a joint venture in the U.S. with their Chinese counterparts as partners. In some cases, Chinese companies may be willing to purchase or become major shareholders in U.S. companies, based partly on the U.S. companies’ IP assets. For many hi-tech start-ups in the U.S., not only will teaming up with a Chinese partner improve their chances of survival, but such a partnership may also provide them a shortcut to China’s lucrative consumer market.
Third, U.S. companies may consider selling Chinese IP rights to their innovations to Chinese companies. Frequently, U.S. companies obtain patents in China and other countries to protect their innovations abroad. If U.S. companies prefer not to sell U.S. IP rights for any reason, selling or licensing Chinese IP rights may be a good option, especially if the U.S. companies do not have the capability or plans to enter the Chinese market.
Fourth, U.S. companies may consider creating a joint venture with their Chinese partners in China. This approach may be more attractive than creating a joint venture in the U.S. in certain situations. Specifically, the Chinese government at all levels has policies in place to support the joint ventures that bring leading technologies to China. If the right technologies are in place, these joint ventures have been known to receive millions of dollars in incentives from the central and/or local governments of China.
Fifth, U.S. companies may attract venture capital for China-related hi-tech projects. Because of the recession, venture capital and private equity firms have become more reluctant to provide funding for start-up companies in the U.S. China-related projects, however, continue to attract investment from both the U.S. and China. Specifically in China, government-backed investment funds, such as Chinese Social Security Fund, have excess cash waiting to be invested in the right technologies.
Finally, while this article does not address U.S export control laws, U.S. companies must consider the implications of such laws before transferring technologies to China.
As China’s economy leads the recovery from this global recession, U.S. innovations can also benefit from China’s $586 billion stimulus plan. U.S. companies, however, must have the technologies that are in demand in China. U.S. companies must also know how to navigate through many complex political and cultural aspects of doing business in China or with Chinese partners. If advised properly, both U.S. and Chinese companies can benefit from the cross-border IP transactions.
Saturday, November 21, 2009
Wednesday, November 18, 2009
Mei & Mark LLP Files an Appeal Brief in the Federal Circuit on Behalf of an Intervenor in Pass & Seymour v. ITC.
The Intellectual Property & Litigation law firm Mei & Mark LLP today filed an appeal brief in the United States Court of Appeals for the Federal Circuit on behalf of Intervenor Wenzhou Trimone Science and Technology Electric Co., Ltd., in Pass & Seymour v. ITC, Case Nos. 2009-1338, -1369. The case is on appeal from the United States International Trade Commission in Investigation No. 337-TA-615. The client retained Mei & Mark LLP for post-ITC proceedings, including appeals, after it lost at the Commission. A copy of the brief is available for download.
Mei & Mark LLP's appellate team consists of registered patent attorneys who possess both exceptional academic credentials in law, science, and technology, and a rare combination of patent law experience covering patent prosecution, licensing, and litigation. The brief is authored by Mr. Lei Mei, a magna cum laude graduate of Duke Law School, where he was elected to the Order of the Coif, and Mr. Reece Nienstadt, a Stanford graduate who holds a J.D. degree, cum laude, from Georgetown University Law Center.
Mei & Mark LLP's appellate team consists of registered patent attorneys who possess both exceptional academic credentials in law, science, and technology, and a rare combination of patent law experience covering patent prosecution, licensing, and litigation. The brief is authored by Mr. Lei Mei, a magna cum laude graduate of Duke Law School, where he was elected to the Order of the Coif, and Mr. Reece Nienstadt, a Stanford graduate who holds a J.D. degree, cum laude, from Georgetown University Law Center.
Tuesday, November 10, 2009
The US Supreme Court Heard the Oral Argument for Bilski v. Kappos on November 9, 2009
Click here for the argument transcript.
Wednesday, November 4, 2009
Does A Patent License Cover All Future Subsidiaries?
Imation Corp. v. Koninklijke Philips Electronics, N.V., Nos. 2009-1208, -1209 (Fed. Cir. Nov. 3, 2009):
Holding:
The use of the phrase “now or hereafter” in the “Subsidiary” definition precludes an implicit, temporal limitation in a patent license. Slip op. at 20.
The “agrees to grant and does hereby grant" language creates singular, present grant of rights to existing and future patents that fall within the definition of “Licensed Patents.” Slip op. at 10.
Relevant Facts:
Philips entered a paid-up cross-license agreement with 3M, which later spun off Imation. The agreement continues between Philips and Imation, in which Philips “agrees to grant and does hereby grant to [Imation] and its SUBSIDIARIES a personal, non-exclusive, indivisible, nontransferable, irrevocable, worldwide, royalty-free license under PHILIPS LICENSED PATENTS.” The term “SUBSIDIARIES” is defined as “business organization as to which the party now or hereafter has more than a fifty percent (50%) ownership interest.” Imation later formed or acquired two subsidiaries after the expiration of the agreement (note that the license is still valid for the life of the patents despite the expiration of the agreement). The dispute is whether these two new subsidiaries are covered by the license agreement. The Federal Circuit sided with Imation.
Comments:
This case illustrates the risks of any patent license agreement (or, really, any agreement). The risks arise because the drafters cannot possibly anticipate all future disputes. As a result, the agreement will inevitably fail to anticipate some scenarios. Accordingly, the drafters must try to minimize the risks by (i) learning from prior cases and (ii) considering as many scenarios as possible.
Because most lawyers never worked in the business world before, it could be difficult for them to fully understand business risks. The knowledge can only come from experience, in practicing law or otherwise.
In this case, the parties must have failed to consider the situation whether one party acquires subsidiaries after the agreement expires.
On the one hand, it appears that the definition of “subsidiaries” is ambiguous, and should be decided by the jury. Because the parties likely failed to anticipate this scenario, however, I doubt any extrinsic evidence exists or can guide the jury.
On the other hand, the Court cleverly found that the language is not ambiguous and made a ruling as a matter of law. It makes sense from a law and economics standpoint. It would have been such a waste of resources if the jury has to decide this issue and the relevant extrinsic evidence either does not exist or does not help.
One thing for sure, however, is that after this case, the drafters will know to further define “subsidiaries” in response to this decision.
Holding:
The use of the phrase “now or hereafter” in the “Subsidiary” definition precludes an implicit, temporal limitation in a patent license. Slip op. at 20.
The “agrees to grant and does hereby grant" language creates singular, present grant of rights to existing and future patents that fall within the definition of “Licensed Patents.” Slip op. at 10.
Relevant Facts:
Philips entered a paid-up cross-license agreement with 3M, which later spun off Imation. The agreement continues between Philips and Imation, in which Philips “agrees to grant and does hereby grant to [Imation] and its SUBSIDIARIES a personal, non-exclusive, indivisible, nontransferable, irrevocable, worldwide, royalty-free license under PHILIPS LICENSED PATENTS.” The term “SUBSIDIARIES” is defined as “business organization as to which the party now or hereafter has more than a fifty percent (50%) ownership interest.” Imation later formed or acquired two subsidiaries after the expiration of the agreement (note that the license is still valid for the life of the patents despite the expiration of the agreement). The dispute is whether these two new subsidiaries are covered by the license agreement. The Federal Circuit sided with Imation.
Comments:
This case illustrates the risks of any patent license agreement (or, really, any agreement). The risks arise because the drafters cannot possibly anticipate all future disputes. As a result, the agreement will inevitably fail to anticipate some scenarios. Accordingly, the drafters must try to minimize the risks by (i) learning from prior cases and (ii) considering as many scenarios as possible.
Because most lawyers never worked in the business world before, it could be difficult for them to fully understand business risks. The knowledge can only come from experience, in practicing law or otherwise.
In this case, the parties must have failed to consider the situation whether one party acquires subsidiaries after the agreement expires.
On the one hand, it appears that the definition of “subsidiaries” is ambiguous, and should be decided by the jury. Because the parties likely failed to anticipate this scenario, however, I doubt any extrinsic evidence exists or can guide the jury.
On the other hand, the Court cleverly found that the language is not ambiguous and made a ruling as a matter of law. It makes sense from a law and economics standpoint. It would have been such a waste of resources if the jury has to decide this issue and the relevant extrinsic evidence either does not exist or does not help.
One thing for sure, however, is that after this case, the drafters will know to further define “subsidiaries” in response to this decision.
Labels:
Case Comment,
Patent Litigation
Subscribe to:
Posts (Atom)